Webinar

Clinical Breakthroughs and Market Evolution in Lung Cancer

We will outline the overview of the current treatments available for lung cancer patients, including the loss of market exclusivity for key products in the space. We will also breaks down the latest developments in lung cancer as the pharmaceutical industry targets earlier stage patients with new drugs and combinations.

Speakers

Sam Fazeli

Head of EMEA Research

Bloomberg

Dr. Shiven Patel

Medical Director

Madison Memorial Hospital in Idaho

Dr. Shiven Patel, MD, MBA, FACP, is the Medical Director of Madison Memorial Hospital in Idaho (2017-present) and an Associate Professor of Oncology at the Huntsman Cancer Institute (09/2015-present) and the George E. Wahlen Department of Veterans Affairs Medical Center (09/2015-present), both in Salt Lake City. Previously, he was a Hospitalist at the MedStar Franklin Square Medical Center in Baltimore (07/2011-06/2012). Dr. Patel is a specialist in adult hematology and medical oncology, and his main areas of interest include thoracic cancers (head and neck, thyroid, lung, mesothelioma, and thymic). He is board-certified in internal medicine, hematology, and oncology and is a member of several national organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the American Association of Cancer Research. Throughout his medical training, Dr. Patel has been involved in both laboratory and clinical research. He has presented his work at multiple national meetings and published the findings in peer-reviewed journals. He is a co-investigator in several clinical trials at the Huntsman Cancer Institute and is working to bring more studies to the Huntsman Cancer Institute to benefit his patients.

Register

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.